Effects of beta-adrenergic blockade on cerebral autoregulation and chemical vasomotor control in patients with stroke.
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002245:Carbon Dioxide / Q000097:blood / Q000494:pharmacology; D002536:Cerebral Arteries / Q000294:innervation; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006985:Hyperventilation; D007427:Intracranial Pressure / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects*; D010313:Partial Pressure; D011187:Posture; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use*; D011941:Receptors, Adrenergic; D014655:Vascular Resistance / Q000187:drug effects; D014666:Vasomotor System / Q000187:drug effects / Q000503:physiopathology; D014690:Venous Pressure / Q000187:drug effects
D001786:Blood Glucose; D011941:Receptors, Adrenergic; D002245:Carbon Dioxide; D011433:Propranolol; D010100:Oxygen